Actively Recruiting
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Led by Thomas Advanced Medical LLC · Updated on 2022-04-29
5000
Participants Needed
1
Research Sites
543 weeks
Total Duration
On this page
Sponsors
T
Thomas Advanced Medical LLC
Lead Sponsor
H
HeartStem Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
CONDITIONS
Official Title
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 and older
- Ability to provide informed consent
- Availability for follow up visits
You will not qualify if you...
- Active or recent malignancy (within last 2 years)
- Pregnancy or breast-feeding
- Inability to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
Culver City, California, United States, 92032
Actively Recruiting
Research Team
P
Paul C Bogaardt, PhD(c), MSc, MBA
CONTACT
K
Karen Mulholland Angelus
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
10
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here